PIK3CA and breast carcinoma: Recent studies in human breast cancer have shown that KAT7 upregulates phosphoinositide 3-kinase (PIK3CA), leading to activation of the PI3K/AKT signaling pathway, which is known to contribute to cell survival and proliferation.